Data from Phase 1b/2 clinical trial to be presented at 2024 San Antonio Breast Cancer Symposium (SABCS) show encouraging clinical activity in patients with heavily pretreated HER2-positive breast ...
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (ALXO),, a clinical-stage biotechnology company advancing therapies that boost the immune system to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results